IDH1 and oligodendroglioma: This case review analyses 4 cases involving Chilean patients with a mutation in IDH1 with different primary malignancies: 1 recurrent oligodendroglioma, 2 malignant biliary tumours, and lastly, a G3 well-differentiated pancreatic neuroendocrine tumour (PanNET, NET G3).